4.6 Article

Mutations in the voltage-sensing domain affect the alternative ion permeation pathway in the TRPM3 channel

期刊

JOURNAL OF PHYSIOLOGY-LONDON
卷 596, 期 12, 页码 2413-2432

出版社

WILEY
DOI: 10.1113/JP274124

关键词

TRP; TRPM3; alternative ion permeation pathway

资金

  1. Belgian Federal Government [IUAP P7/13]
  2. Research Foundation-Flanders [G.0565.07, G.0825.11, G084515N]
  3. Research Council of the KU Leuven [IOF-HB/12/023]
  4. Research Council of the KU Leuven (PF-TRPLe)
  5. European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [665501]
  6. research Foundation Flanders (FWO)

向作者/读者索取更多资源

Transient receptor potential (TRP) channels are cationic channels involved in a broad array of functions, including homeostasis, motility and sensory functions. TRP channel subunits consist of six transmembrane segments (S1-S6), and form tetrameric channels with a central pore formed by the region encompassing S5 and S6. Recently, evidence was provided for the existence of an alternative ion permeation pathway in TRPM3, which allows large inward currents upon hyperpolarization independently of the central pore. However, very little knowledge is available concerning the localization of this alternative pathway in the native TRPM3 channel protein. Guided by sequence homology with Shaker K+ channels, in which mutations in S4 can create an analogous omega' pore, we performed site-directed mutagenesis studies and patch clamp experiments to identify amino acid residues involved in the formation of the non-canonical pore in TRPM3. Based on our results, we pinpoint four residues in S4 (W982, R985, D988 and G991) as crucial determinants of the properties of the alternative ion permeation pathway.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pharmacology & Pharmacy

Pharmacological properties of TRPM3 isoforms are determined by the length of the pore loop

Katharina Held, Vincenzo Davide Aloi, Ana Cristina Nogueira Freitas, Annelies Janssens, Andrei Segal, Julia Przibilla, Stephan Ernst Philipp, Yu Tian Wang, Thomas Voets, Joris Vriens

Summary: This study compares the pharmacological properties of different splice variants of TRPM3, demonstrating that the length of the pore-forming loop in the alternative splicing region defines the channel's activation by specific compounds.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Article Neurosciences

The selective dopamine D1 receptor agonist SKF81297 modulates NMDA receptor currents independently of D1 receptors

Maya O. Nesbit, Anping Chai, Peter Axerio-Cilies, Anthony G. Phillips, Yu Tian Wang, Katharina Held

Summary: The widely used dopamine D-1 receptor agonist SKF81297 can modulate neurotransmission by potentiating glutamatergic NMDAR currents independently of D1R activation. These findings have important implications for interpreting studies on dopamine functions that rely on these compounds.

NEUROPHARMACOLOGY (2022)

Article Biology

Machine learning-assisted fluoroscopy of bladder function in awake mice

Helene De Bruyn, Nikky Corthout, Sebastian Munck, Wouter Everaerts, Thomas Voets

Summary: Understanding the lower urinary tract (LUT) is crucial for developing novel therapies for LUT disorders. We developed a videocystometry technique to accurately monitor the LUT in rodents, but it had limitations in awake and freely moving animals. To overcome this, we used machine learning to automatically analyze bladder filling and voiding cycles in behaving mice. Our findings revealed the effects of anesthesia on urethral relaxation and voiding duration, as well as the decreased bladder capacity after surgical implantation of a catheter. This approach provides a paradigm for noninvasive, in vivo monitoring of hollow organs in behaving animals and highlights the limitations of current standard techniques for studying the LUT in mice.
Article Obstetrics & Gynecology

The impact of chronic endometritis on infertility: prevalence, reproductive outcomes, and the role of hysteroscopy as a screening tool

Brecht Geysenbergh, Anne-Sophie Boes, Celine Bafort, Anne-Sophie van Rompuy, Sara Neyens, Sharon Lie Fong, Sophie Debrock, Joris Vriens, Peter De Loecker, Eline Dancet, Thomas D'Hooghe, Karen Peeraer

Summary: This study aimed to investigate the prevalence of chronic endometritis (CE) in infertile women, its impact on reproductive outcomes, and the accuracy of hysteroscopy as a screening tool for CE. The study included 514 asymptomatic patients with infertility who underwent hysteroscopy and endometrial biopsy (EMB). CE was identified in 2.8% of patients starting assisted reproductive technologies (ART). The clinical pregnancy rate (CPR) did not differ significantly between patients with CE and the entire cohort of patients without CE, but was significantly lower in the 2 years after EMB in patients with CE compared to matched controls. Hysteroscopy had low sensitivity and high specificity in diagnosing CE.

GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2023)

Article Biology

Gain- of- function variants in the ion channel gene TRPM3 underlie a spectrum of neurodevelopmental disorders

Lydie Burglen, Evelien Van Hoeymissen, Leila Qebibo, Magalie Barth, Newell Belnap, Felix Boschann, Christel Depienne, Katrien De Clercq, Andrew G. L. Douglas, Mark P. Fitzgerald, Nicola Foulds, Catherine Garel, Ingo Helbig, Katharina Held, Denise Horn, Annelies Janssen, Angela M. Kaindl, Vinodh Narayanan, Christina Prager, Mailys Rupin-Mas, Alexandra Afenjar, Siyuan Zhao, Vincent Th Ramaekers, Sarah M. Ruggiero, Simon Thomas, Stephanie Valence, Lionel Van Maldergem, Tibor Rohacs, Diana Rodriguez, David Dyment, Thomas Voets, Joris Vriens

Summary: TRPM3 is a plasma membrane cation channel that is sensitive to temperature and neurosteroids and is expressed in various types of cells. Rare variants in TRPM3 have been found in individuals with developmental and epileptic encephalopathy, but the connection between TRPM3 activity and neurological disorders is not well understood. In this study, we identified additional heterozygous missense variants in TRPM3 in 10 patients with a range of neurodevelopmental symptoms. These variants cause a gain-of-function phenotype, leading to increased channel activity and altered calcium levels in cells. Treatment with the TRPM3 antagonist primidone reduced the increased channel activity, suggesting that TRPM3 antagonists could be a potential therapy for these disorders.
Article Pharmacology & Pharmacy

pH-dependent modulation of TRPV1 by modality-selective antagonists

Jan Daniluk, Thomas Voets

Summary: TRPV1 antagonists have pH-dependent effects on channel inhibition, but their modality selectivity is not strict. The antagonistic efficacy of TRPV1 antagonists is limited at acidic pH, which may restrict their analgesic efficacy in injured tissues.

BRITISH JOURNAL OF PHARMACOLOGY (2023)

Article Clinical Neurology

Primidone improves symptoms in TRPM3-linked developmental and epileptic encephalopathy with spike-and-wave activation in sleep

Lena-Luise Becker, Denise Horn, Felix Boschann, Evelien Van Hoeymissen, Thomas Voets, Joris Vriens, Christine Prager, Angela M. Kaindl

Summary: DEE-SWAS is an age-dependent disease that causes cognitive decline. This study reports on two children with DEE-SWAS and developmental delay/regression, who had missense variants in the TRPM3 gene. Treatment with primidone improved their developmental regression, psychomotor development, and eliminated CSWS.

EPILEPSIA (2023)

Article Pharmacology & Pharmacy

Inhibition of TRPM8 by the urinary tract analgesic drug phenazopyridine

Noemie Luyts, Jan Daniluk, Ana Cristina Nogueira Freitas, Bahar Bazeli, Annelies Janssens, Marie Mulier, Wouter Everaerts, Thomas Voets

Summary: In this study, the effect of Phenazopyridine (PAP) on pain-related Transient Receptor Potential (TRP) channels was investigated. The results showed that PAP can rapidly and reversibly inhibit the cold and menthol sensitivity of TRPM8 channels. This suggests that the inhibition of TRPM8 may be the mechanism underlying the analgesic activity of PAP.

EUROPEAN JOURNAL OF PHARMACOLOGY (2023)

Article Anesthesiology

TRPM3 as a novel target to alleviate acute oxaliplatin-induced peripheral neuropathic pain

Vincenzo Davide Aloi, Silvia Joao Poseiro Coutinho Pinto, Rita Van Bree, Katrien Luyten, Thomas Voets, Joris Vriens

Summary: Chemotherapy-induced peripheral neuropathic pain (CIPNP) is a common adverse effect in cancer patients receiving cytostatic drugs. Current treatment options for CIPNP are limited and unsatisfactory. This study suggests that TRPM3 could be a potential target for the treatment of neuropathic pain in chemotherapy patients.
暂无数据